NCTY
The9 Limited
There isn't enough reported data to score NCTY yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
NCTY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate NCTY's fundamentals.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
NCTY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 1.3x | $2.73 | — |
| Cheap | 3.4x | N/A | N/A |
| Fair | 5x | N/A | N/A |
| Expensive | 6.6x | N/A | N/A |
Historical ranges are pointers, not guarantees.
NCTY's PE is 1.3x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
NCTY Forward outlook
There aren't enough analyst estimates for NCTY to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
NCTY Earnings Per Share
NCTY and NVDA do not have enough comparable growth data to identify a winner.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
NCTY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.7M | -71% |
| Q4 2025 | $6.8M | +125% |
| Q2 2025 | $9.2M | -34% |
| Q4 2024 | $3M | -76% |
| Q2 2024 | $13.9M | -4.4% |
| Q4 2023 | $12.3M | +31% |
| Q2 2023 | $14.6M | +112% |
| Q4 2022 | $9.4M | +520% |
NCTY's revenue has slid since its 2021 peak: $3M last quarter, down 81% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1077% | -1020 points |
| Q4 2025 | -399% | -353 points |
| Q2 2025 | -111% | +178 points |
| Q4 2024 | -549% | -281 points |
| Q2 2024 | -57% | +491 points |
| Q4 2023 | -46% | +2161 points |
| Q2 2023 | -289% | -214 points |
| Q4 2022 | -267% | -2386 points |
NCTY's operating margin was −1077% last quarter, down 1020 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over NCTY in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over NCTY on profitability, with a higher operating margin.
NCTY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.2M | -465% |
| Q4 2025 | -$5M | +$4.4M |
| Q2 2025 | $1.2M | +$1.2M |
| Q4 2024 | -$9.3M | -$9.3M |
| Q2 2024 | $0 | $0 |
| Q4 2023 | $0 | -100% |
| Q2 2023 | $0 | $0 |
| Q4 2020 | -$6.7M | -$1.1M |
NCTY's free cash flow was −$17M over the past year, against $30M the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
NCTY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -31% | -4.7M shares |
| 1 year | +148% | +6.3M shares |
| 3 years | +2363% | +10.1M shares |
| 5 years | +13503% | +10.5M shares |
| Available history | +12768% | +10.5M shares |
NCTY has 11M diluted shares, up 148% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2025 | — |
| Q2 2025 | — |
| Q4 2024 | — |
| Q2 2024 | — |
| Q4 2023 | — |
| Q2 2023 | — |
| Q4 2022 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over NCTY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
NCTY Net Leverage
NCTY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
NCTY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.0 | Neutral |
| Stochastic | 3.9 | Oversold |
NCTY's weekly RSI is 35 (neutral) and its Stochastic is 4 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
NCTY PE vs Technology Sector
| Metric | NCTY | Sector median | Relative |
|---|---|---|---|
| PE | 1.3x | 28x | 96% below |
| PE % | 3 | 35 | 32 pts below |
NCTY has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
NCTY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.17 | 14% below |
| 20 week MA | $3.93 | 31% below |
| 50 week MA | $5.10 | 46% below |
| 100 week MA | $8.04 | 66% below |
| 200 week MA | $8.03 | 66% below |
NCTY is in a downtrend: it's below all five of its weekly moving averages, and 66% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over NCTY on trend strength, trading above more of its moving averages.
NCTY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $92.0 | $28.9 | -69% |
| 2021 | $28.9 | $81.1 | +181% |
| 2022 | $81.1 | $6.20 | -92% |
| 2023 | $6.20 | $7.49 | +21% |
| 2024 | $7.49 | $15.7 | +110% |
| 2025 | $15.7 | $7.04 | -55% |
| 2026 YTD | $7.04 | $2.73 | -61% |
NCTY's yearly returns have swung widely, from +181% in 2021 to −92% in 2022. It's down 61% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over NCTY on returns for 2026, with the stronger performance.